Association of Non-Invasive Markers with Significant Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study.
Fan ZhangYan HanLiming ZhengJianhong LiuYunfei WuZuowei BaoLonggen LiuWenjian LiPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2023)
The diagnostic model constructed by CHI3L1 combined with the existing non-invasive markers AST, IV-C, and LSM can help assess the risk of significant liver fibrosis in NAFLD.